Nexalin Technology (NXL) Gains from Investment Securities (2022 - 2026)
Nexalin Technology's quarterly Gains from Investment Securities came in at $315104.0 in Q1 2026, up 1466.2% year-on-year from $20119.0 in Q1 2025, and up 2880.9% quarter-over-quarter from -$11331.0 in Q4 2025.
Nexalin Technology has reported Gains from Investment Securities for 5 years, with the latest figure at $315104.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 1466.2% year-over-year to $315104.0; the trailing twelve-month figure through Mar 2026 stood at $315104.0 (up 577.18% YoY), and the FY2025 full-year result was $4.1 million, up 33.92% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $315104.0, up from -$11331.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.9 million in Q3 2024, with the low at -$11331.0 in Q4 2025.
- Average Gains from Investment Securities over 5 years is $554580.1, with a median of $48825.0 recorded in 2023.
- Peak annual rise in Gains from Investment Securities reached 4492.67% in 2023, while the deepest fall reached 96.66% in 2023.
- Tracing NXL's Gains from Investment Securities over 5 years: stood at $1340.0 in 2022, then grew by 9.48% to $1467.0 in 2023, then surged by 195068.98% to $2.9 million in 2024, then slumped by 100.4% to -$11331.0 in 2025, then jumped by 2880.9% to $315104.0 in 2026.
- The last three Gains from Investment Securities figures came in at $315104.0 (Q1 2026), -$11331.0 (Q4 2025), and $130000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 315,104.00 |
| Mar 31, 2026 | 315,104.00 |
| Dec 31, 2025 | -11,331.00 |
| Dec 31, 2025 | -11,331.00 |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 581,250.00 |
| Jun 30, 2025 | 581,250.00 |
| Mar 31, 2025 | 20,119.00 |
| Mar 31, 2025 | 20,119.00 |
| Sep 30, 2024 | 2.86 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 24,946.00 |
| Mar 31, 2024 | 24,946.00 |
| Dec 31, 2023 | 1,467.00 |
| Dec 31, 2023 | 1,467.00 |
| Sep 30, 2023 | 82,943.00 |
| Sep 30, 2023 | 82,943.00 |
| Jun 30, 2023 | 58,878.00 |
| Jun 30, 2023 | 58,878.00 |
| Mar 31, 2023 | 38,772.00 |
| Mar 31, 2023 | 38,772.00 |
| Dec 31, 2022 | 1,340.00 |
| Dec 31, 2022 | 1,340.00 |
| Sep 30, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1,282.00 |
| Jun 30, 2022 | 1,282.00 |
| Mar 31, 2022 | 1,254.00 |
| Mar 31, 2022 | 1,254.00 |